Breakthrough Research Suggests Existing Breast Cancer Drugs could be Used to Treat Certain Types of Lung Cancers

 Breast cancer drugs can also be used to treat certain targeted therapy resistant lung cancers, according to a new study. The study, conducted on mice, found that the mutations in the gene EGFR were responsible for certain lung tumors in mice. When protein p110a was blocked by drugs, the tumor shrank in size. P110a blocking …

New Product Launches to Drive Negative Pressure Wound Therapy Adoption

Companies Develop Remote Therapy Monitoring Program KCI, an Acelity Firm, global leader in the advanced wound management along with Highmark Inc., a nationwide spread healthcare insurance provider, have taken immense efforts in developing iOn PROGRESS™ Remote Therapy Monitoring Program. This new development is based on a performance-based agreement that aims in improving the overall patient …

Technological Innovations to Transform Breast Pumps Landscape

Pentagon Spends Nearly $1,400 in Electric Breast Pump Pentagon has spent approximately $1,400 in electric breast pump, which goes for nearly $192 in stores. On a broader aspect, DHA (Defense Health Agency) overpaid around $16.2Million for the standard electric breast pump as well as replacement parts offered to the beneficiaries in former West, South and …

Rapidly Growing Healthcare Sector Contributes to Boosting Applications of Intraoperative MRI Equipment in the Hospitals Market

Recent improvements in the quality of life and growing health consciousness among consumers across the world are playing an important role in the development of the healthcare sector. The rapidly growing healthcare sector is the primary factor that is boosting the use of technologically advanced medical appliances such as intraoperative MRI equipment in the hospitals …

Horizon Discovery Group Partners With C4X Discovery Holdings to Develop Oncology Drugs

Horizon Discovery Group Plc, a UK-based company which specializes in gene editing and modification, recently entered into an exclusive partnership with C4X Discovery Holdings, a pioneer in drug discovery. The partnership aims at developing and delivering oncology drugs for conditions that have very limited or no effective treatments available in the market such as colorectal …

Tiny Implantable Device could help Combat Obesity Epidemic

Scientists have created a battery-free, easy-to-implant device that makes the brain think of the stomach as full after eating only a few nibbles of food. The device is capable of fighting the growing issue of obesity, worldwide. When the researchers from the University of Wisconsin-Madison in the US tried the device in laboratory testing, it …

Health Canada Proposes Limit on Alcohol Amount in Sugary Premixed Beverages

Health Canada has taken an initiative to alleviate the quantity of alcohol permitted in the premixed sugary drinks. According to the agency, the growing amount of alcohol in such beverages are putting the health of public especially youngsters, at risk. In a news release, the government agency said that such beverages can have nearly more …

Alira Health Acquires Clinical Insights to Attain Better Data Science Capabilities

In a recent announcement, one of the leading international healthcare and life sciences advisory firms Alira Health disclosed that it has purchased a data science organization Clinical Insights, which offers data analytics and predictive analysis to wide range of companies operating in the healthcare industry. With this acquisition, every practice area of Alira Health, be …

Australia-Based Company Gets Recognized for Path Breaking Cancer Treatment Technology

OncoRes Medical a technology start-up based in Perth, Australia has been given global recognition for its attempts to improve the results of breast cancer surgery. Digital Imagery to Play Major Role OncoRes Medical created an imaging tool for surgeries that generates digital images of cancerous tissue. Currently, the primary method for tumor identification is through …

FDA Approves New Orphan Drug for Frontotemporal Dementia

Orphan Drug Designation to Foster Rising Consumption of Drug Orphan drugs are developed specifically for the treatment of rare medical conditions that are known as orphan diseases. Approvals of the US Food and Drug Administration (FDA) play a crucial role in the implementation of drugs for treatment. The new and first-of-its-kind protein aggregation inhibitor LMTX …